Equities

Trulieve Cannabis Corp

  • Add to watchlist
  • Add to portfolio
  • Add an alert

Trulieve Cannabis Corp

Actions
  • Price (EUR)5.47
  • Today's Change0.150 / 2.82%
  • Shares traded500.00
  • 1 Year change+25.72%
  • Beta1.6766
Data delayed at least 15 minutes, as of Feb 16 2026 08:05 GMT.
More ▼
Notice
Important Notice
Please note that effective 5th February, 2026 the Financial Times will no longer publish or present securities from the Nairobi Stock Exchange.

Profile data is unavailable for this security.

About the company

Trulieve Cannabis Corp. is a vertically integrated cannabis company. The Company has established cannabis operations in three hubs: Southeast, Northeast, and Southwest. Each of its three regional hubs is anchored by market positions in the cornerstone states of Florida, Pennsylvania, and Arizona. The Company operates in regulated markets that require expertise in cultivation, manufacturing, and retail. The Company utilizes various extraction techniques, including supercritical ethanol extraction, carbon dioxide extraction, hydrocarbon extraction, and mechanical separation. In addition, it utilizes distillation, purification, and manufacturing technologies to further refine extracts and transform them into a wide variety of finished products. Its brands include premium-tier brands Avenue, Cultivar Collection, and Muse; mid-tier brands Modern Flower, Alchemy, Momenta, and Sweet Talk, and value tier brands Co2lors, Loveli, Roll One, and Trekkers.

  • Revenue in CAD (TTM)1.62bn
  • Net income in CAD-170.51m
  • Incorporated2018
  • Employees5.40k
  • Location
    Trulieve Cannabis Corp6749 Ben Bostic RoadQUINCY 32351United StatesUSA
  • Phone+1 (850) 298-8866
  • Fax+1 (647) 497-5345
  • Websitehttps://www.trulieve.com/
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.